Doughnut Hole Is Gone, But Medicare’s Uncapped Drug Costs Still Bite Into Budgets

Michelle Andrews Three times a week, Tod Gervich injects himself with Copaxone, a prescription drug that can reduce the frequency of relapses in people who have some forms of multiple sclerosis. After more than 20 years with the disease, Gervich, 66, is accustomed to managing his condition. What he can’t get used to is howContinue reading Doughnut Hole Is Gone, But Medicare’s Uncapped Drug Costs Still Bite Into Budgets